Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
0.3756
-0.0330 (-8.08%)
At close: May 19, 2026, 4:00 PM EDT
0.3503
-0.0253 (-6.74%)
Pre-market: May 20, 2026, 6:05 AM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Specialized Biotherapeutics | | 119.37K | 395.12K | 31.93K | - | 117.37K | | | | |
Specialized Biotherapeutics Growth | | -69.79% | 1137.51% | - | - | -90.44% | | | | |
| | - | 444.24K | 916.98K | 824.27K | 2.24M | | | | |
Public Health Solutions Growth | | - | -51.55% | 11.25% | -63.24% | -34.10% | | | | |
| | 119.37K | 839.36K | 948.91K | 824.27K | 2.36M | | | | |
| | -85.78% | -11.55% | 15.12% | -65.07% | -49.04% | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | 119.37K | 839.36K | 948.91K | 824.27K | 2.36M | | | | |
| | -85.78% | -11.55% | 15.12% | -65.07% | -49.04% | | | | |
| | 119.37K | 839.36K | 948.91K | 824.27K | 2.36M | | | | |
| | -85.78% | -11.55% | 15.12% | -65.07% | -49.04% | | | | |
Source: S&P Global Market Intelligence.
